BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 26323351)

  • 1. Evaluation of fluorophore-tethered platinum complexes to monitor the fate of cisplatin analogs.
    Jagodinsky JC; Sulima A; Cao Y; Poprawski JE; Blackman BN; Lloyd JR; Swenson RE; Gottesman MM; Hall MD
    J Biol Inorg Chem; 2015 Oct; 20(7):1081-95. PubMed ID: 26323351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dinuclear platinum anticancer complexes with fluorescent N,N'-bis(aminoalkyl)-1,4-diaminoanthraquinones: cellular processing in two cisplatin-resistant cell lines reflects the differences in their resistance profiles.
    Kalayda GV; Jansen BA; Wielaard P; Tanke HJ; Reedijk J
    J Biol Inorg Chem; 2005 May; 10(3):305-15. PubMed ID: 15824924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly Emissive Self-Assembled BODIPY-Platinum Supramolecular Triangles.
    Zhou J; Zhang Y; Yu G; Crawley MR; Fulong CRP; Friedman AE; Sengupta S; Sun J; Li Q; Huang F; Cook TR
    J Am Chem Soc; 2018 Jun; 140(24):7730-7736. PubMed ID: 29787269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platinum(II) complexes of imidazophenanthroline-based polypyridine ligands as potential anticancer agents: synthesis, characterization, in vitro cytotoxicity studies and a comparative ab initio, and DFT studies with cisplatin, carboplatin, and oxaliplatin.
    Alexander C; Nithyakumar A; Paul MWB; Arockia Samy N
    J Biol Inorg Chem; 2018 Jul; 23(5):833-848. PubMed ID: 29934700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platinum compounds for high-resolution in vivo cancer imaging.
    Miller MA; Askevold B; Yang KS; Kohler RH; Weissleder R
    ChemMedChem; 2014 Jun; 9(6):1131-5. PubMed ID: 24504646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterodinuclear Pt(iv)-Ru(ii) anticancer prodrugs to combat both drug resistance and tumor metastasis.
    Ma L; Ma R; Wang Z; Yiu SM; Zhu G
    Chem Commun (Camb); 2016 Sep; 52(71):10735-8. PubMed ID: 27506281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational design of dicarboxylato platinum(II) complexes with purine-mimetic ligands as novel anticancer agents.
    Hoffmann K; Wiśniewska J; Wojtczak A; Sitkowski J; Denslow A; Wietrzyk J; Jakubowski M; Łakomska I
    J Inorg Biochem; 2017 Jul; 172():34-45. PubMed ID: 28477537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of platinum(II) and (IV) complexes of 1,3-diaminepropane and 1,4-diaminebutane: circumvention of cisplatin resistance and DNA interstrand cross-link formation in CH1cisR ovarian tumor cells.
    Alvarez-Valdés A; Pérez JM; López-Solera I; Lannegrand R; Continente JM; Amo-Ochoa P; Camazón MJ; Solans X; Font-Bardía M; Navarro-Ranninger C
    J Med Chem; 2002 Apr; 45(9):1835-44. PubMed ID: 11960495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, Spectroscopic Properties, Crystal Structure And Biological Evaluation of New Platinum Complexes with 5-methyl-5-(2-thiomethyl)ethyl Hydantoin.
    Bakalova AG; Buyukliev RT; Nikolova RP; Shivachev BL; Mihaylova RA; Konstantinov SM
    Anticancer Agents Med Chem; 2019; 19(10):1243-1252. PubMed ID: 30767754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platinum(IV)-nitroxyl complexes as possible candidates to circumvent cisplatin resistance in RT112 bladder cancer cells.
    Cetraz M; Sen V; Schoch S; Streule K; Golubev V; Hartwig A; Köberle B
    Arch Toxicol; 2017 Feb; 91(2):785-797. PubMed ID: 27307157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
    Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
    J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose-conjugated platinum(IV) complexes as tumor-targeting agents: design, synthesis and biological evaluation.
    Wang H; Yang X; Zhao C; Wang PG; Wang X
    Bioorg Med Chem; 2019 Apr; 27(8):1639-1645. PubMed ID: 30852077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pt(II) complexes with bidentate and tridentate pyrazolyl-containing chelators: synthesis, structural characterization and biological studies.
    Francisco C; Gama S; Mendes F; Marques F; dos Santos IC; Paulo A; Santos I; Coimbra J; Gabano E; Ravera M
    Dalton Trans; 2011 Jun; 40(21):5781-92. PubMed ID: 21512700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro evaluation of the enantiomeric R- and S-1,1'-binaphthyl-2,2'-diaminodichlorido-Pt(ii) complexes in human Burkitt lymphoma cells: emphasis on cellular accumulation, cytotoxicity, DNA binding, and ability to induce apoptosis.
    Sørensen BH; Werth P; Lambert IH; Bednarski PJ
    Metallomics; 2018 Feb; 10(2):323-336. PubMed ID: 29333543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular accumulation and cytotoxicity of macromolecular platinum complexes in cisplatin-resistant tumor cells.
    Garmann D; Warnecke A; Kalayda GV; Kratz F; Jaehde U
    J Control Release; 2008 Oct; 131(2):100-6. PubMed ID: 18691617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and in vitro anticancer activity of octahedral platinum(IV) complexes with cyclohexyl-functionalized ethylenediamine-N,N'-diacetate-type ligands.
    Lazić JM; Vucićević L; Grgurić-Sipka S; Janjetović K; Kaluderović GN; Misirkić M; Gruden-Pavlović M; Popadić D; Paschke R; Trajković V; Sabo TJ
    ChemMedChem; 2010 Jun; 5(6):881-9. PubMed ID: 20408161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipophilic Pt(II) complexes with selective efficacy against cisplatin-resistant testicular cancer cells.
    Biersack B; Dietrich A; Zoldakova M; Kalinowski B; Paschke R; Schobert R; Mueller T
    J Inorg Biochem; 2011 Dec; 105(12):1630-7. PubMed ID: 22071088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic malonate platinum(II) complexes with 1,2,4-triazolo[1,5-a]pyrimidine derivatives: structural characterization and mechanism of the suppression of tumor cell growth.
    Łakomska I; Hoffmann K; Wojtczak A; Sitkowski J; Maj E; Wietrzyk J
    J Inorg Biochem; 2014 Dec; 141():188-197. PubMed ID: 25277461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of cytotoxicities of platinum compounds.
    Goodisman J; Hagrman D; Tacka KA; Souid AK
    Cancer Chemother Pharmacol; 2006 Jan; 57(2):257-67. PubMed ID: 16028101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic activities, cellular uptake, gene regulation, and optical imaging of novel platinum(II) complexes.
    Gao J; Liu YG; Zingaro RA
    Chem Res Toxicol; 2009 Oct; 22(10):1705-12. PubMed ID: 19694485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.